- ►atsjournals.org TE KING JR, MI SCHWARZ, K BROWN, JA … - American journal of respiratory and critical care …, 2001 - Am Thoracic Soc It is hypothesized that the extent and severity of fibrosis and cellularity
found on lung biopsy determine the prognosis and response to therapy in
idiopathic pulmonary fibrosis (IPF). The objective of this study was to ... Cited by 288 - Related articles - BL Direct - All 5 versions
- ►im.org [PDF] M Demedts, J Behr, R Buhl, U Costabel, R … - The New England journal of medicine, 2005 - nejm.highwire.org From University Hospital, Katholieke Uni- versiteit Leuven, Leuven, Belgium (MD,
MT, EKV, JV); Medizinische Klinik I, Klinikum Grosshadern der Ludwig-Maxi-
milians-Universität, Munich, Germany (JB); Medizinische Klinik III, ... Cited by 222 - Related articles - All 17 versions
- ►nih.gov CE Daniels, MC Wilkes, M Edens, TJ Kottom, … - Journal of Clinical Investigation, 2004 - Am Soc Clin Investig Idiopathic pulmonary fibrosis is a progressive and fatal fibrotic disease of the
lungs with unclear etiology. Prior efforts to treat idiopathic pulmonary
fibrosis that focused on anti-inflammatory therapy have not proven to be ... Cited by 199 - Related articles - BL Direct - All 7 versions
F Zuo, N Kaminski, E Eugui, J Allard, Z … - Proceedings of the National Academy of Sciences of …, 2002 - National Acad Sciences Pulmonary fibrosis is a progressive and largely untreatable group of disorders
that affects up to 100,000 people on any given day in the United States. To
elucidate the molecular mechanisms that lead to end-stage human pulmonary ... Cited by 200 - Related articles - BL Direct - All 7 versions
- ►atsjournals.org AQ Thomas, K Lane, J Phillips III, M Prince, … - American Journal of respiratory and critical care …, 2002 - Am Thoracic Soc Familial pulmonary fibrosis is a heterogeneous group of interstitial lung
diseases of unknown cause that is associated with multiple pathologic subsets.
Mutations in the surfactant protein C (SP-C) gene (SFTPC) are associated ... Cited by 199 - Related articles - All 7 versions
M Selman - Chest, 2001 - chestjournal.chestpubs.org Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and usually fatal
lung disease of no identifiable etiology, characterized by fibroblast
proliferation and extracellular matrix accumulation resulting in ... Cited by 168 - Related articles - BL Direct - All 12 versions
H Kasai, JT Allen, RM Mason, T Kamimura, Z … - Respiratory research, 2005 - biomedcentral.com A549 cells were examined for evidence of EMT after treatment with TGF-β1. EMT
was assessed by: morphology under phase-contrast microscopy; Western analysis of
cell lysates for expression of mesenchymal phenotypic markers including ... Cited by 115 - Related articles - Cached - All 10 versions
M Selman, A Pardo, L Barrera, A Estrada, SR … - American journal of respiratory and critical care …, 2006 - 171.66.122.149 From the 1Instituto Nacional de Enfermedades Respiratorias, Tlalpan 4502; CP
14080, Mexico DF, México, 2Facultad de Ciencias, Universidad Nacional Autónoma
de México, CP 04510, 3Eos Biotechnology, South San Francisco, CA 94080 and ... Cited by 108 - Related articles - View as HTML - BL Direct - All 10 versions
- ►jimmunol.org P Bonniaud, M Kolb, T Galt, J Robertson, C … - The Journal of Immunology, 2004 - Am Assoc Immnol Transforming growth factor- 1 plays a key role in the pathogenesis of pulmonary
fibrosis, mediating extracellular matrix (ECM) gene expression through a series
of intracellular signaling molecules, including Smad2 and Smad3. We show ... Cited by 106 - Related articles - BL Direct - All 4 versions
- ►171.66.122.149 RG Crystal, PB Bitterman, B Mossman, MI … - American journal of respiratory and critical care …, 2002 - 171.66.122.149 Idiopathic pulmonary fibrosis (IPF) is an insidious inflammatory
fibroproliferative disease whose cause and course before diagnosis are unknown,
and for which existing treatments are of limited benefit. The National ... Cited by 103 - Related articles - BL Direct - All 6 versions
